{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:41:24Z","timestamp":1772775684794,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T00:00:00Z","timestamp":1447718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.nefro.2015.11.003","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T22:15:21Z","timestamp":1450822521000},"page":"10-18","source":"Crossref","is-referenced-by-count":7,"title":["Efectos pleiotr\u00f3picos del paricalcitol, m\u00e1s all\u00e1 del metabolismo \u00f3seo-mineral"],"prefix":"10.1016","volume":"36","author":[{"given":"Jes\u00fas","family":"Egido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Mart\u00ednez-Castelao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Bover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Praga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Vicente","family":"Torregrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"Fern\u00e1ndez-Gir\u00e1ldez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Soloz\u00e1bal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2015.11.003_bib0240","doi-asserted-by":"crossref","first-page":"419524","DOI":"10.4061\/2011\/419524","article-title":"Vitamin D receptor activators and clinical outcomes in chronic kidney disease","volume":"2011","author":"Gravellone","year":"2011","journal-title":"Int J Nephrol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0245","first-page":"697","article-title":"Efectividad del tratamiento con paricalcitol por v\u00eda oral en pacientes con enfermedad renal cr\u00f3nica en etapas anteriores a la di\u00e1lisis","volume":"31","author":"Herv\u00e1s S\u00e1nchez","year":"2011","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefro.2015.11.003_bib0250","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2165\/00003495-200767140-00002","article-title":"Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism. Understanding the differences among therapies","volume":"67","author":"Brancaccio","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.nefro.2015.11.003_bib0255","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2005.10.007","article-title":"Paricalcitol en c\u00e1psulas para el tratamiento del hiperparatiroidismo secundario de enfermedad renal cr\u00f3nica en estadios 3 y 4","volume":"47","author":"Coyne","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2015.11.003_bib0260","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefro.2015.11.003_bib0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.semnephrol.2011.11.009","article-title":"Role of vitamin D receptor activators in cardio-renal syndromes","volume":"32","author":"Cozzolino","year":"2012","journal-title":"Semin Nephrol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0475","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl."},{"key":"10.1016\/j.nefro.2015.11.003_bib0275","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.ki.5000045","article-title":"Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation","volume":"69","author":"Andress","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2015.11.003_bib0280","doi-asserted-by":"crossref","first-page":"F1502","DOI":"10.1152\/ajprenal.00130.2009","article-title":"A new role for vitamin D receptor activation in chronic kidney disease","volume":"297","author":"Valdivielso","year":"2009","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0285","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/ndt\/gfh123","article-title":"Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings","volume":"19","author":"Dobrez","year":"2004","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2015.11.003_bib0290","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: A historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0295","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2015.11.003_bib0300","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.jrn.2006.07.006","article-title":"Impact of kidney bone disease and its management on survival of patients on dialysis","volume":"17","author":"Lee","year":"2007","journal-title":"J Ren Nutr."},{"key":"10.1016\/j.nefro.2015.11.003_bib0305","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1093\/ndt\/gfn375","article-title":"Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats","volume":"12","author":"Noonan","year":"2008","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2015.11.003_bib0310","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/jpet.106.101261","article-title":"Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification","volume":"318","author":"Wu-Wong","year":"2006","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1016\/j.nefro.2015.11.003_bib0315","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.ki.5002406","article-title":"Differential effects of vitamin D receptor activators on vascular calcification in uremic rats","volume":"72","author":"Mizobuchi","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2015.11.003_bib0320","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1681\/ASN.2008070692","article-title":"Vascular calcification: The killer of patients with chronic kidney disease","volume":"20","author":"Mizobuchi","year":"2009","journal-title":"Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0325","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.070305","article-title":"Differential effects of vitamin D analogs on vascular calcification","volume":"22","author":"Card\u00fas","year":"2007","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.nefro.2015.11.003_bib0480","doi-asserted-by":"crossref","first-page":"625852","DOI":"10.1155\/2010\/625852","article-title":"Vitamin d receptor activation mitigates the impact of uremia on endothelial function in the 5\/6 nephrectomized rats","volume":"2010","author":"Wu-Wong","year":"2010","journal-title":"Int J Endocrinol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0335","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000097812","article-title":"Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells","volume":"44","author":"Wu-Wong","year":"2007","journal-title":"J Vasc Res."},{"key":"10.1016\/j.nefro.2015.11.003_bib0340","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000319445","article-title":"Effects of paricalcitol and enalapril on atherosclerotic injury in mouse aortas","volume":"32","author":"Husain","year":"2010","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0345","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1159\/000178251","article-title":"Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats","volume":"29","author":"Husain","year":"2009","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0350","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1523-1755.2002.00450.x","article-title":"Update on vitamin D and its newer analogues: Actions and rationale for treatment in chronic renal failure","volume":"62","author":"Malluche","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2015.11.003_bib0355","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1681\/ASN.2007060666","article-title":"Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-KB signaling","volume":"19","author":"Tan","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0360","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1681\/ASN.2006050520","article-title":"Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy","volume":"17","author":"Tan","year":"2006","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0365","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","article-title":"Antiproteinuric effect of oral paricalcitol in chronic kidney disease","volume":"68","author":"Agrawal","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2015.11.003_bib0370","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.ajkd.2009.04.036","article-title":"Oral paricalcitol in the treatment of patients with CKD and proteinuria: A randomized trial","volume":"54","author":"Fishbane","year":"2009","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2015.11.003_bib0375","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): A randomised controlled trial","volume":"376","author":"De Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.nefro.2015.11.003_bib0380","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease. A randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.nefro.2015.11.003_bib0385","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2215\/CJN.03000311","article-title":"Efficacy and safety of paricalcitol therapy for chronic kidney disease: A meta-analysis","volume":"7","author":"Cheng","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0390","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.coph.2010.04.001","article-title":"Vitamin D: Modulator of the immune system","volume":"10","author":"Baeke","year":"2010","journal-title":"Curr Opin Pharmacol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0395","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clim.2009.06.011","article-title":"Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells","volume":"133","author":"Schorov\u00e1","year":"2009","journal-title":"Clin Immunol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0400","unstructured":"Navarro-Gonz\u00e1lez JF, M\u00e9ndez ML, Mora C, Muros M, Gallego E, et al. Oral paricalcitol improves inflammatory profile in haemodialysis patients. P\u00f3ster presentado en el Congreso de la ISN en Vancouver; 2011."},{"key":"10.1016\/j.nefro.2015.11.003_bib0405","doi-asserted-by":"crossref","first-page":"F647","DOI":"10.1152\/ajprenal.00090.2011","article-title":"Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy","volume":"302","author":"S\u00e1nchez-Ni\u00f1o","year":"2012","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0410","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.transproceed.2010.07.077","article-title":"Effect of paricalcitol on the urinary peptidome of kidney transplant patients","volume":"42","author":"P\u00e9rez","year":"2010","journal-title":"Transplant Proc."},{"key":"10.1016\/j.nefro.2015.11.003_bib0415","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1046\/j.1523-1755.1999.00589.x","article-title":"Reduced parathyroid functional mass after successful kidney transplantation","volume":"56","author":"Bonarek","year":"1999","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.nefro.2015.11.003_bib0420","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.ajkd.2006.04.066","article-title":"Changes of coronary calcification after kidney transplantation","volume":"48","author":"Oschatz","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2015.11.003_bib0425","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1681\/ASN.2008091005","article-title":"Significance and management of proteinuria in kidney transplant recipients","volume":"20","author":"Amer","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2015.11.003_bib0430","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1111\/j.1600-6143.2007.02006.x","article-title":"Proteinuria after kidney transplantation, relationship to allograft histology and survival","volume":"7","author":"Amer","year":"2007","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefro.2015.11.003_bib0435","doi-asserted-by":"crossref","first-page":"iii47","DOI":"10.1093\/ndt\/gfh1015","article-title":"Proteinuria: A new marker of long-term graft and patient survival in kidney transplantation","volume":"19","author":"Fern\u00e1ndez-Fresnedo","year":"2004","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"10.1016\/j.nefro.2015.11.003_bib0440","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.trre.2011.07.006","article-title":"New options and perspectives for proteinuria management after kidney transplantation","volume":"26","author":"Soler","year":"2012","journal-title":"Transplant Rev (Orlando)."},{"issue":"1","key":"10.1016\/j.nefro.2015.11.003_bib0445","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.trre.2011.07.007","article-title":"Management of proteinuria in clinical practice after kidney transplantation","volume":"26","author":"Ruiz","year":"2012","journal-title":"Transplant Rev (Orlando)."},{"key":"10.1016\/j.nefro.2015.11.003_bib0485","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/TP.0b013e3182855565","article-title":"Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients","volume":"95","author":"Gonzalez","year":"2013","journal-title":"Transplantation."},{"issue":"Suppl 2","key":"10.1016\/j.nefro.2015.11.003_bib0455","first-page":"189","article-title":"Vitamin D analogues reduce proteinuria in kidney transplant (KTx) patients","volume":"9","author":"Palya","year":"2009","journal-title":"Am J Transplant."},{"issue":"12","key":"10.1016\/j.nefro.2015.11.003_bib0460","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/ki.2010.69","article-title":"Paricalcitol attenuates cyclosporine-induced kidney injury in rats","volume":"77","author":"Park","year":"2010","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.nefro.2015.11.003_bib0465","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.nefro.2015.11.003_bib0470","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ahj.2012.09.018","article-title":"Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease","volume":"164","author":"Tamez","year":"2012","journal-title":"Am Heart J"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699515002325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699515002325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T13:50:14Z","timestamp":1537105814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699515002325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0211699515002325"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2015.11.003","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}